Hussain Aamir 4
4 · Liberty Latin America Ltd. · Filed Jul 17, 2026
Research Summary
AI-generated summary of this filing
Liberty Latin America SVP Hussain Aamir Receives Preferred Dividend
What Happened
- Hussain Aamir, SVP, CT&PO of Liberty Latin America (tickers: LILA / LILAB / LILAK; Pref ticker LILAP), received 60,770 Series A 9.0% Fixed Rate Cumulative Perpetual Redeemable Preferred Shares on June 16, 2026 as a special dividend (reported on Form 4). The preferred shares were received at $0 (dividend) and have an initial liquidation price of $25 per share — an implied initial liquidation value of about $1.52M (60,770 × $25).
- The filing also shows derivative adjustments (treated as "Other acquisition or disposition (J)") reported June 17, 2026: additional derivative share amounts of 7,086; 13,458; and 17,419 shares. These represent adjustments to existing Share Appreciation Rights (SARs) under the issuer’s anti‑dilution provisions following the dividend, not new cash purchases.
Key Details
- Transaction dates: Preferred dividend payable June 16, 2026; SAR adjustments reported June 17, 2026. Filing date: July 17, 2026 (filed ~31 days after the primary transaction).
- Price: All items reported as acquired at $0. Preferred initial liquidation price stated as $25 per share.
- Shares acquired: 60,770 Preferred Shares; derivative adjustments of 7,086; 13,458; 17,419 SAR‑related shares.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Notable footnotes: F1 documents the special dividend (0.10 preferred share per common share); multiple footnotes (F10–F22, etc.) state prior SAR amounts and that SARs were adjusted under anti‑dilution provisions and approved by the compensation committee. Vesting schedules vary by award (some vest in 2027, some in installments through 2029; some may be fully vested).
- Timeliness: Filing appears late relative to the transaction (transaction date June 16, filing July 17) — the Form 4 was not filed within the typical 2 business days.
Context
- This transaction is a corporate special dividend distribution of preferred shares and administrative adjustments to equity awards (SARs). Receiving a dividend is not the same as an insider buy; the derivative entries reflect contractual anti‑dilution adjustments to existing awards rather than open‑market purchases or exercises for cash.
- The SAR adjustments change the number of underlying shares and base prices per the incentive plan’s anti‑dilution terms; vesting and exercise rules remain governed by the original award documents and the compensation committee’s approvals.
Insider Transaction Report
Form 4
Hussain Aamir
SVP, CT&PO
Transactions
- Other
Series A Preference Shares
[F1]2026-06-16+60,770→ 60,770 total - Other
Restricted Share Units P
[F2][F3][F4]2026-06-17+7,086→ 7,086 total→ Series A Preference Shares (7,086 underlying) - Other
Restricted Share Units P
[F2][F3][F5]2026-06-17+13,458→ 13,458 total→ Series A Preference Shares (13,458 underlying) - Other
Restricted Share Units P
[F2][F3][F6]2026-06-17+17,419→ 17,419 total→ Series A Preference Shares (17,419 underlying)
Holdings
- 148,854
Share Appreciation Rights A
[F7][F8]Exercise: $7.52Exp: 2032-04-18→ Class A Common Shares (148,854 underlying) - 306,036
Share Appreciation Rights C
[F7][F9]Exercise: $7.28Exp: 2032-04-18→ Class C Common Shares (306,036 underlying) - 143,000
Share Appreciation Rights A
[F7][F10]Exercise: $7.52Exp: 2032-04-19→ Class A Common Shares (143,000 underlying) - 294,000
Share Appreciation Rights C
[F7][F11]Exercise: $7.28Exp: 2032-04-19→ Class C Common Shares (294,000 underlying) - 154,650
Share Appreciation Rights A
[F7][F12]Exercise: $5.47Exp: 2033-03-20→ Class A Common Shares (154,650 underlying) - 317,952
Share Appreciation Rights C
[F7][F13]Exercise: $5.30Exp: 2033-03-20→ Class C Common Shares (317,952 underlying) - 191,803
Share Appreciation Rights A
[F14][F15]Exercise: $4.31Exp: 2034-03-12→ Class A Common Shares (191,803 underlying) - 394,336
Share Appreciation Rights C
[F14][F16]Exercise: $4.24Exp: 2034-03-12→ Class C Common Shares (394,336 underlying) - 177,272
Share Appreciation Rights A
[F17][F18]Exercise: $4.68Exp: 2035-03-14→ Class A Common Shares (177,272 underlying) - 364,461
Share Appreciation Rights C
[F17][F19]Exercise: $4.54Exp: 2035-03-14→ Class C Common Shares (364,461 underlying) - 156,951
Share Appreciation Rights A
[F20][F21]Exercise: $5.31Exp: 2036-03-13→ Class A Common Shares (156,951 underlying) - 322,682
Share Appreciation Rights C
[F20][F22]Exercise: $5.29Exp: 2036-03-13→ Class C Common Shares (322,682 underlying)
Footnotes (22)
- [F1]On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 60,770 Preferred Shares.
- [F10]This share appreciation right award ("SAR") was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $10.75 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F11]This share appreciation right award ("SAR") was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $10.70 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F12]This share appreciation right award ("SAR") was previously reported as a SAR relating to 108,147 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F13]This share appreciation right award ("SAR") was previously reported as a SAR relating to 216,294 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F14]The SARs vest in full on March 15 2027.
- [F15]This share appreciation right award ("SAR") was previously reported as a SAR relating to 134,128 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F16]This share appreciation right award ("SAR") was previously reported as a SAR relating to 268,256 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F17]The SARs vest in two equal annual installments on March 15 of 2027 and 2028.
- [F18]This share appreciation right award ("SAR") was previously reported as a SAR relating to 123,967 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F19]This share appreciation right award ("SAR") was previously reported as a SAR relating to 247,933 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F2]Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
- [F20]The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
- [F21]This share appreciation right award ("SAR") was previously reported as a SAR relating to 109,756 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F22]This share appreciation right award ("SAR") was previously reported as a SAR relating to 219,512 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F3]In connection with the Dividend, all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F4]The Restricted Share Units vest in full on March 15, 2027.
- [F5]The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
- [F6]The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
- [F7]The derivative security is fully vested.
- [F8]This share appreciation right award ("SAR") was previously reported as a SAR relating to 104,094 shares of the Issuer's common stock at a base price of $10.75 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F9]This share appreciation right award ("SAR") was previously reported as a SAR relating to 208,188 shares of the Issuer's common stock at a base price of $10.70 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Signature
/s/ John M. Winter, Attorney-in-Fact|2026-07-17